Chemical Biology and Drug Design
Chemical Biology and Drug Design
5 years ago

Inhibition of tyrosinase by 4H-chromene analogs: Synthesis, kinetic studies, and computational analysis

Inhibition of tyrosinase by 4H-chromene analogs: Synthesis, kinetic studies, and computational analysis
José L. M. Nascimento, Edikarlos M. Brasil, Edilene O. Silva, Érica T. C. Cardoso, Barbarella M. Macchi, Jerônimo Lameira, Cláudio N. Alves, Dharmarajan Sriram, Vera L. Eifler-Lima, Luciana M. Canavieira, Craig M. Williams, José Rogério Araújo Silva, Paul V. Bernhardt
Inhibition of mushroom tyrosinase was observed with synthetic dihydropyrano[3,2-b]chromenediones. Among them, DHPC04 displayed the most potent tyrosinase inhibitory activity with a Ki value of 4 μm, comparable to the reference standard inhibitor kojic acid. A kinetic study suggested that these synthetic heterocyclic compounds behave as competitive inhibitors for the L-DOPA binding site of the enzyme. Furthermore, molecular modeling provided important insight into the mechanism of binding interactions with the tyrosinase copper active site. An inhibitory study involving development of new compounds with Tyrosinase activity by using experimental and computational techniques.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/cbdd.13001

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.